Buenos Aires

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Asthma2 trials
• Coeliac disease1 trial
• COPD1 trial

Phase

• Phase 23 trials
• Phase 31 trial

Status

• Active, not recruiting2 trials
• Enrolling by invitation1 trial
• Recruiting1 trial

Lead sponsor

• Sanofi4 trials

Running trials

• Recruiting

  Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

  NCT07190222· Phase 3· Sanofi· Source

• Active, not recruiting

  Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma

  NCT06676319· Phase 2· Sanofi· Source

• Enrolling by invitation

  Long-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With Asthma

  NCT06609239· Phase 2· Sanofi· Source

• Active, not recruiting

  A Phase 2a/b Study of the Efficacy and Safety of Subcutaneous Amlitelimab in Adults With Nonresponsive Celiac Disease

  NCT06557772· Phase 2· Sanofi· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Asthma1 recruiting
• COPD1 recruiting